TransCelerate Logo
TransCelerate Logo
Powered by Google TranslateTranslate

 Virtual Controls, Real Impact: Transforming Preclinical Research

 

Date: Tuesday, May 12, 2026

Time: 9:30 to 10:30 a.m. ET

 

Virtual control groups (VCGs) are gaining attention as a way to reduce reliance on traditional concurrent controls in preclinical toxicology. Anchored in experience from the European Innovative Health Initiative (IHI) project VICT3R, this webinar brings together consortia, industry, and regulatory perspectives to support engagement in this emerging area. 

 

During this webinar, our panelists will:

  • Provide an introduction to VCGs and the current landscape
  • Share early lessons learned from the IHI VICT3R project
  • Discuss scientific and regulatory considerations for future adoption

Panelists:

  • William Houser, Scientific Associate Director, Nonclinical Safety, Bristol-Myers Squibb  
  • Karolina Kopanska, Postdoctoral Toxicologist, Johns Hopkins Center for Alternatives to Animal Testing (CAAT)
  • Lars Mecklenburg, Executive Director, Data & Science, Labcorp Early Development 
  • Lilliam Rosario, Program Director, TransCelerate
  • Thomas Steger-Hartmann, Senior Project Lead, Innovative Health Initiative; VP, Bayer AG

 This event does not constitute nor should be considered as any type of endorsement by TransCelerate or its members of any vendor, product, or technology. TransCelerate webinars may be recorded in whole or in part.